Radovan Komel
Ljubljana, Slovenia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
The Slovenian translational platform GlioBank for brain tumor research: Identification of molecular signatures of glioblastoma progression.
Journal: Neuro-oncology advances
Published: February 18, 2025
Anti-Vimentin Nanobody Decreases Glioblastoma Cell Invasion In Vitro and In Vivo.
Journal: Cancers
Published: December 07, 2022
Inflammatory landscape in Xeroderma pigmentosum patients with cutaneous melanoma.
Journal: Scientific reports
Published: March 25, 2022
TRIM28 Selective Nanobody Reduces Glioblastoma Stem Cell Invasion.
Journal: Molecules (Basel, Switzerland)
Published: July 06, 2021
Genetic variations in AURORA cell cycle kinases are associated with glioblastoma multiforme.
Journal: Scientific reports
Published: June 17, 2021
Cytoskeletal proteins as glioblastoma biomarkers and targets for therapy: A systematic review.
Journal: Critical reviews in oncology/hematology
Published: August 14, 2020
Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in Glioblastoma Cell Lines and Extracellular Vesicles.
Journal: International journal of molecular sciences
Published: May 31, 2020
Anti-vimentin, anti-TUFM, anti-NAP1L1 and anti-DPYSL2 nanobodies display cytotoxic effect and reduce glioblastoma cell migration.
Journal: Therapeutic advances in medical oncology
Published: July 30, 2019
Characterization and risk association of polymorphisms in Aurora kinases A, B and C with genetic susceptibility to gastric cancer development.
Journal: BMC cancer
Published: October 02, 2018
Meta-Analysis and Experimental Validation Identified FREM2 and SPRY1 as New Glioblastoma Marker Candidates.
Journal: International journal of molecular sciences
Published: February 16, 2018
Last Updated: 09/26/2026